Workflow
Concentra Group Holdings Parent, Inc.(CON)
icon
Search documents
CON EDISON REPORTS 2024 EARNINGS
Prnewswire· 2025-02-20 21:36
Financial Performance - Consolidated Edison reported a net income of $1,820 million or $5.26 per share for 2024, a decrease from $2,519 million or $7.25 per share in 2023 [1] - Adjusted earnings for 2024 were $1,868 million or $5.40 per share, compared to $1,762 million or $5.07 per share in 2023 [1] - For Q4 2024, net income was $310 million or $0.90 per share, down from $335 million or $0.97 per share in Q4 2023 [2] Strategic Initiatives - The company is focused on supporting clean energy technologies and enhancing electric service reliability, with significant capital investments planned for grid infrastructure [3] - Con Edison anticipates steady growth in demand for electrification in 2025, driven by new construction and clean heat requirements [3] Future Guidance - For 2025, Con Edison expects adjusted earnings per share to be in the range of $5.50 to $5.70, excluding certain impacts related to its equity investments [3] - The company projects a five-year compounded annual adjusted earnings per share growth rate of 6% to 7% based on its 2025 guidance [3] Capital Investment Plans - Con Edison plans to invest $5,122 million in 2025 and $8,067 million in 2026, with a total of $24,469 million expected from 2027 to 2029 [4] - The company intends to finance these capital requirements through internally-generated funds and the issuance of long-term debt and common equity [4] Revenue and Expenses - Total operating revenues for 2024 were $15,256 million, an increase from $14,663 million in 2023, with electric revenues rising to $11,568 million [14] - Total operating expenses for 2024 were $12,524 million, compared to $12,332 million in 2023, with notable increases in purchased power and maintenance costs [14] Impact of Clean Energy Businesses Sale - The sale of Con Edison's Clean Energy Businesses in 2023 had significant impacts on earnings, with adjustments reflecting losses and gains related to this transaction [11][19] - The company recorded a loss of $62 million related to the sale for the year ended December 31, 2024 [14]
Concentra (CON) Upgraded to Strong Buy: Here's What You Should Know
ZACKS· 2025-01-23 18:01
Core Viewpoint - Concentra Group (CON) has received a Zacks Rank 1 (Strong Buy) upgrade, indicating a positive outlook driven by an upward trend in earnings estimates [1][3]. Earnings Estimates and Stock Price Movement - The Zacks rating system is based on changes in a company's earnings picture, which significantly influences stock price movements [2][4]. - An increase in earnings estimates typically leads to higher fair value calculations by institutional investors, resulting in buying or selling pressure that affects stock prices [4]. Implications of the Upgrade - The upgrade reflects an improvement in Concentra's underlying business, suggesting that investors may respond positively by driving the stock price higher [5][10]. - The Zacks Rank system has a strong track record, with Zacks Rank 1 stocks averaging a +25% annual return since 1988, indicating potential for market-beating returns [7][10]. Earnings Estimate Revisions for Concentra - For the fiscal year ending December 2024, Concentra is expected to earn $1.47 per share, representing a year-over-year decline of -15% [8]. - Over the past three months, the Zacks Consensus Estimate for Concentra has increased by 1.6%, reflecting analysts' growing confidence in the company's earnings outlook [8]. Zacks Rating System Overview - The Zacks rating system maintains a balanced distribution of 'buy' and 'sell' ratings across its universe of over 4000 stocks, with only the top 5% receiving a 'Strong Buy' rating [9][10]. - Concentra's upgrade to Zacks Rank 1 places it among the top 5% of stocks covered by Zacks, indicating strong potential for price appreciation in the near term [10].
Best Value Stocks to Buy for January 10th
ZACKS· 2025-01-10 09:21
Group 1: United Airlines Holdings, Inc. (UAL) - United Airlines Holdings has a Zacks Rank 1 and a price-to-earnings ratio (P/E) of 8.63, significantly lower than the industry average of 19.70 [1] - The Zacks Consensus Estimate for its current year earnings has increased by 0.9% over the last 60 days [1] - The company possesses a Value Score of A, indicating strong value characteristics [1] Group 2: Concentra Group Holdings Parent, Inc. (CON) - Concentra Group Holdings has a Zacks Rank 1 and a price-to-earnings ratio (P/E) of 15.51, compared to the S&P average of 24.66 [2] - The Zacks Consensus Estimate for its current year earnings has increased by 1.4% over the last 60 days [2] - The company also possesses a Value Score of A, reflecting strong value characteristics [2] Group 3: ICF International, Inc. (ICFI) - ICF International carries a Zacks Rank 1 and has a price-to-earnings ratio (P/E) of 14.65, lower than the S&P average of 24.66 [3] - The Zacks Consensus Estimate for its current year earnings has increased by 2.9% over the last 60 days [3] - The company possesses a Value Score of B, indicating solid value characteristics [3]
Watts Water Buys I-CON Systems to Expand Digital Plumbing Solutions
ZACKS· 2025-01-07 15:17
Acquisition and Market Expansion - Watts Water Technologies, Inc. (WTS) has acquired I-CON Systems Inc., a leading provider of plumbing control solutions for the corrections market, fully funded with cash on hand [1] - I-CON has estimated annualized sales revenues of $25 million and specializes in vandal-proof, cost-effective water management systems tailored for correctional facilities, which will enhance WTS' portfolio [2] - The acquisition is expected to positively contribute to WTS' revenue stream and diversify its market presence, focusing on innovation and long-term growth opportunities [3] Recent Acquisitions and Financial Performance - WTS is actively pursuing acquisitions to sustain top-line momentum, having recently acquired Josam Company, which has annualized revenues of approximately $35 million, and Bradley Corporation for $303 million [4] - The acquisitions of Bradley and Josam contributed $59 million to sales in the Americas region for Q3 2024, with anticipated acquired sales from these companies in the range of $205-$210 million for 2024 [5] - WTS reported a year-over-year sales increase of 8% to $543.6 million, surpassing the Zacks Consensus Estimate by 0.9% [6] Financial Outlook Adjustments - Following recent momentum, WTS has raised the midpoint of its operating margin forecast by 20 basis points and narrowed its sales guidance, expecting reported sales growth of 9% to 10% [7] - Organic sales are anticipated to decline by 1% to 2%, a revision from the previous forecast of a 7-12% increase in reported sales and a potential organic sales decline of 4% to an increase of 1% [7] Stock Performance - WTS currently holds a Zacks Rank 3 (Hold), with shares rising 2.5% over the past year, compared to a sub-industry growth of 5.1% [8]
CON EDISON REPORTS 2024 THIRD QUARTER EARNINGS
Prnewswire· 2024-11-07 21:42
Core Insights - Consolidated Edison, Inc. reported a net income of $588 million or $1.70 per share for Q3 2024, an increase from $526 million or $1.53 per share in Q3 2023 [1] - For the first nine months of 2024, net income was $1,510 million or $4.37 per share, down from $2,185 million or $6.27 per share in the same period of 2023 [2] - Adjusted earnings for Q3 2024 were $583 million or $1.68 per share, compared to $561 million or $1.62 per share in Q3 2023 [1] - The company expects adjusted earnings per share for 2024 to be in the range of $5.30 to $5.40, revised from the previous range of $5.20 to $5.40 [3] Financial Performance - The adjusted earnings for the first nine months of 2024 were $1,528 million or $4.42 per share, compared to $1,416 million or $4.07 per share in the same period of 2023 [2] - The adjusted earnings exclude the effects of hypothetical liquidation at book value accounting for tax equity investments and adjustments related to the sale of the Clean Energy Businesses [2][3] - The company reported a total of approximately $15 billion in annual revenues for year-end 2023 and $69 billion in assets as of September 30, 2024 [9] Strategic Initiatives - The company is focusing on investments in clean energy infrastructure and energy-efficient solutions, which have helped manage electric demand during peak periods [3] - Con Edison is facilitating the transition to electrification by making it easier to install EV chargers and providing incentives for heat pump installations [3] - The company aims to enhance its infrastructure to improve resilience against climate change while supporting New York's clean energy transition [3]
Concentra Group Holdings Parent, Inc.(CON) - 2024 Q3 - Quarterly Report
2024-11-06 16:59
Company Operations - As of September 30, 2024, the company operated 549 standalone occupational health centers and 156 onsite health clinics across 45 states and the District of Columbia[69]. - The company’s telemedicine program serves 43 states and the District of Columbia, expanding its reach in occupational health services[69]. - The company’s operating segments include Occupational Health Centers, Onsite Health Clinics, and Other Businesses, with similar economic characteristics[73]. Financial Performance - Revenue from Occupational Health Centers accounted for 95% of total revenue for both the three and nine months ended September 30, 2024[74]. - Revenue increased 3.3% to $489.6 million for the three months ended September 30, 2024, compared to $473.9 million for the same period in 2023[91]. - Revenue increased 2.7% to $1,435.2 million for the nine months ended September 30, 2024, compared to $1,397.3 million for the same period in 2023[100]. - Revenue per visit increased 3.9% to $141.42 for the three months ended September 30, 2024, compared to $136.11 for the same period in 2023[93]. - Revenue per visit increased 4.1% to $140.12 for the nine months ended September 30, 2024, compared to $134.62 for the same period in 2023[102]. Patient Visits - The company reported a daily patient visit volume (VPD) of 45% for workers' compensation services for the three months ended September 30, 2024[76]. - Total patient visits decreased to 3,258,605 for the three months ended September 30, 2024, from 3,281,042 in the same period of 2023[92]. - Total patient visits for the nine months ended September 30, 2024, were 9,628,515, down from 9,766,881 in the same period of 2023[101]. - Workers' compensation VPD volume increased 1.5% to 22,733 for the nine months ended September 30, 2024, compared to 22,391 for the same period in 2023[101]. Costs and Expenses - Cost of services was $351.1 million, or 71.7% of revenue, for the three months ended September 30, 2024, compared to $336.8 million, or 71.1% of revenue, for the same period in 2023[94]. - Cost of services was $1,027.4 million, or 71.6% of revenue, for the nine months ended September 30, 2024, compared to $994.7 million, or 71.2% of revenue, for the same period in 2023[103]. - General and administrative expenses were $37.1 million, or 7.6% of revenue, for the three months ended September 30, 2024, compared to $38.2 million, or 8.1% of revenue, for the same period in 2023[95]. - General and administrative expenses were $110.8 million, or 7.7% of revenue, for the nine months ended September 30, 2024, compared to $109.9 million, or 7.9% of revenue, for the same period in 2023[104]. Net Income and Cash Flow - Net income attributable to the Company was $44.3 million for the three months ended September 30, 2024, compared to $53.1 million for the same period in 2023[88]. - Adjusted EBITDA for the nine months ended September 30, 2024, was $299.3 million, compared to $293.0 million for the same period in 2023[115]. - Net cash provided by operating activities was $180.9 million for the nine months ended September 30, 2024, compared to $158.1 million for the same period in 2023[117]. - Cash at the end of the period increased to $136.8 million as of September 30, 2024, from $23.7 million at the end of the same period in 2023[117]. Debt and Financing - The company completed an IPO on July 26, 2024, raising net proceeds of $499.7 million from the sale of 22,500,000 shares at $23.50 per share[78]. - The Concentra credit facilities include a term loan of $850 million and a revolving credit facility of $400 million, with the latter being undrawn at the IPO closing[78]. - The company had outstanding borrowings under its term loan of $850.0 million as of September 30, 2024[126]. - Interest expense increased to $21.4 million for the three months ended September 30, 2024, compared to $0.1 million for the same period in 2023, due to the issuance of an $850.0 million term loan and $650.0 million senior notes[98]. - Interest expense on related party debt decreased to $22.0 million for the nine months ended September 30, 2024, from $33.8 million for the same period in 2023[108]. Risks and Strategic Initiatives - The company faces risks including labor shortages, regulatory changes, and potential disruptions from public health threats[67]. - The company has experienced higher labor costs due to inflation and competitive labor market conditions, which may adversely affect its financial condition if costs continue to rise[135]. - The company has implemented strategies to mitigate inflationary pressures, including selective price increases and supply chain optimization initiatives[135]. - The company intends to pursue continued organic growth and strategic acquisitions to expand its footprint and customer base[128]. - Future dividends are at the discretion of the company's Board of Directors, considering financial condition, operating results, and cash needs[133]. Tax and Interest Rate - The effective tax rate increased to 25.0% for the nine months ended September 30, 2024, compared to 23.5% for the same period in 2023[110]. - The company is subject to interest rate risk with an outstanding $850.0 million term loan, excluding unamortized original issue discounts and debt issuance costs of $13.0 million[136]. - A 0.25% increase in market interest rates will impact the annual interest expense on the company's variable rate debt by $2.1 million per year[137]. Dividends - The company declared a cash dividend of $0.0625 per share on October 28, 2024, payable on November 22, 2024, to stockholders of record as of November 13, 2024[132]. - During Q3 2024, net proceeds from the IPO and debt financing transactions, except for $34.7 million, were paid to Select through dividends and repayment of promissory notes[130].
Concentra Group Holdings Parent, Inc.(CON) - 2024 Q3 - Quarterly Results
2024-10-31 20:41
Financial Performance - Revenue for Q3 2024 was $489.6 million, a 3.3% increase from $474.0 million in Q3 2023[3] - Net income for Q3 2024 was $45.8 million, with earnings per share of $0.37, down from $54.4 million and $0.51 in Q3 2023[4] - Adjusted EBITDA for Q3 2024 was $101.6 million, a 2.7% increase from $98.9 million in Q3 2023, with an Adjusted EBITDA margin of 20.7%[4] - Revenue for Q3 2024 was $1,435,151, a 2.7% increase from $1,397,341 in Q3 2023[22] - Net income attributable to Concentra decreased to $145,031 in Q3 2024, down 4.7% from $152,112 in Q3 2023[22] - Basic and diluted earnings per share (EPS) for Q3 2024 was $1.32, compared to $1.46 in Q3 2023[22] - Net income for the nine months ended September 30, 2024, was $149,097,000, a decrease of 4.6% from $155,887,000 in 2023[32] - Adjusted net income attributable to common shares for the three months ended September 30, 2024, was $44,308,000, compared to $53,040,000 in the same period of 2023, reflecting a decrease of 16.5%[50] - Net income for September 2024 was $45,759,000, a decrease of 16% compared to $54,424,000 in September 2023[46] Operational Metrics - Patient visits totaled 3,258,605 in Q3 2024, averaging 50,916 visits per day, a decrease of 2.2% from Q3 2023[3] - Revenue per visit increased to $141.42, up 3.9% from $136.11 in Q3 2023[3] - Total occupational health centers increased to 549, compared to 539 at the end of Q3 2023[3] - Workers' compensation patient visits for the nine months ended September 30, 2024, totaled 4,364,824, an increase of 2.1% from 4,276,717 in 2023[39] - Revenue per visit for Workers' Compensation increased to $198.62 in 2024, up 2.0% from $194.74 in 2023[39] - Total patient visits decreased by 1.4% to 9,628,515 in 2024 from 9,766,881 in 2023[39] - The number of occupational health centers increased to 549 at the end of the period, up from 539 in 2023, reflecting a growth of 1.9%[35] Cash Flow and Balance Sheet - Cash balance as of September 30, 2024, was $136.8 million, with total debt of $1,482.3 million[6] - Total current assets increased to $409,957 in Q3 2024 from $294,418 in Q4 2023, reflecting a significant growth[29] - Total liabilities rose to $2,179,810 in Q3 2024, up from $1,156,121 in Q4 2023[29] - Net cash provided by operating activities for Q3 2024 was $65,908, compared to $58,597 in Q3 2023[30] - Cash and cash equivalents at the end of Q3 2024 were $136,822, a significant increase from $23,680 at the end of Q3 2023[30] - Net cash provided by operating activities increased to $180,963,000 in 2024 from $158,138,000 in 2023, representing a growth of 14.4%[32] - Cash and cash equivalents at the end of the period increased to $136,822,000 in 2024 from $23,680,000 in 2023[32] Future Outlook - For the full year 2024, the company expects revenue to be approximately $1.9 billion and Adjusted EBITDA in the range of $370.0 million to $375.0 million[10] - Full year 2024 Adjusted EBITDA expectations range from $370 million to $375 million[55] Corporate Actions - The Board of Directors declared a cash dividend of $0.0625 per share, payable on November 22, 2024[8] - Concentra completed an IPO on July 26, 2024, raising net proceeds of $499.7 million from the sale of 22,500,000 shares[11] Other Financial Metrics - Interest expense on related party debt decreased to $21,980 in Q3 2024 from $33,831 in Q3 2023[22] - The company reported an increase in other operating income by 88.1%, reaching $284 in Q3 2024 compared to $151 in Q3 2023[22] - The company incurred a loss of $3,676 from equity in losses of unconsolidated subsidiaries, a significant increase from a loss of $526 in Q3 2023[22] - Net cash used in investing activities was $(54,579,000) in 2024, compared to $(47,125,000) in 2023, indicating an increase in investment outflows[32] - The company acquired 3 occupational health centers during the nine months ended September 30, 2024, compared to 1 in 2023[39] - Income tax expense for September 2024 was $16,415,000, an increase from $15,205,000 in September 2023[46] - Interest expense for September 2024 was $21,369,000, significantly higher than $64,000 in September 2023[46] - Stock compensation expense for September 2024 was $168,000, compared to no expense in September 2023[46] - Depreciation and amortization for September 2024 was $15,213,000, down from $17,959,000 in September 2023[46] - Separation transaction costs for September 2024 were $(44,000), indicating a reduction in costs compared to the previous year[46]